Testing Characteristics
AGIRD (Automated Glucose Reading Insulin Dispenser)
            The automated glucose-reading element of the device will need to be tested to determine its overall accuracy.  To test for the level of accuracy of the GlucoWatch Biographer, the results calculated by the monitor were compared to that of the standard finger-prick test.  According to the Cynus’ test reports, the glucose-monitoring element has a 71% acceptable accuracy rate when compared to that of the standard finger-prick.  Based on these results, we estimate that our monitoring component will have a comparable level of accuracy. 
            Also approved by the FDA for medical use, the insulin patch has proven itself effectual in it duties of dispensing insulin through the skin.  However due to our planned modifications, further testing will be required for our modified insulin patches.
Software Testing Requirements
            Before we commence with the creating of the prototype, we must thoroughly test the proper function of our software.  AGRID plans to implement an independent testing agency.  Testing agencies are often implemented in projects such as this to ensure the integrity of their design.